Early analysis of trial data suggests the vaccine Pfizer is producing with BioNTech could be 90% effective at preventing Covid-19 infection.
Early analysis of trial data suggests the vaccine Pfizer is producing with BioNTech could be 90% effective at preventing Covid-19 infection.